Master Regulator Analysis of the SARS-CoV-2/Human Interactome

被引:135
|
作者
Guzzi, Pietro H. [1 ]
Mercatelli, Daniele [2 ]
Ceraolo, Carmine [2 ]
Giorgi, Federico M. [2 ]
机构
[1] Univ Catanzaro, Dept Surg & Med Sci, Catanzaro 88100, Italy
[2] Univ Bologna, Dept Pharm & Biotechnol, Bologna 40126, Italy
关键词
coronavirus; bioinformatics; gene network analysis; COVID-19; SARS-CoV-2; CONVERTING ENZYME 2; CASPASE-DEPENDENT APOPTOSIS; MULTIPLE SEQUENCE ALIGNMENT; E3 UBIQUITIN LIGASE; GENE-TRANSCRIPTION; VIRUS-REPLICATION; CORONAVIRUS; COMPLEX; PROTEIN; SARS;
D O I
10.3390/jcm9040982
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The recent epidemic outbreak of a novel human coronavirus called SARS-CoV-2 causing the respiratory tract disease COVID-19 has reached worldwide resonance and a global effort is being undertaken to characterize the molecular features and evolutionary origins of this virus. In this paper, we set out to shed light on the SARS-CoV-2/host receptor recognition, a crucial factor for successful virus infection. Based on the current knowledge of the interactome between SARS-CoV-2 and host cell proteins, we performed Master Regulator Analysis to detect which parts of the human interactome are most affected by the infection. We detected, amongst others, affected apoptotic and mitochondrial mechanisms, and a downregulation of the ACE2 protein receptor, notions that can be used to develop specific therapies against this new virus.
引用
收藏
页码:1 / 16
页数:15
相关论文
共 50 条
  • [21] Genetic Control of Human Infection with SARS-CoV-2
    Kucher, A. N.
    Babushkina, N. P.
    Sleptcov, A. A.
    Nazarenko, M. S.
    RUSSIAN JOURNAL OF GENETICS, 2021, 57 (06) : 627 - 641
  • [22] The effects of SARS-CoV-2 on susceptible human cells
    Klestova, Zinaida
    ACTA VIROLOGICA, 2023, 67
  • [23] The Short- and Long-Range RNA-RNA Interactome of SARS-CoV-2
    Ziv, Omer
    Price, Jonathan
    Shalamova, Lyudmila
    Kamenova, Tsveta
    Goodfellow, Ian
    Weber, Friedemann
    Miska, Eric A.
    MOLECULAR CELL, 2020, 80 (06) : 1067 - +
  • [24] The potential effects of clinical antidiabetic agents on SARS-CoV-2
    Qu, Hua
    Zheng, Yi
    Wang, Yuren
    Li, Hongwei
    Liu, Xiufei
    Xiong, Xin
    Zhang, Linlin
    Gu, Jing
    Yang, Gangyi
    Zhu, Zhiming
    Zheng, Hongting
    Ouyang, Qin
    JOURNAL OF DIABETES, 2021, 13 (03) : 243 - 252
  • [25] Sequence similarity of SARS-CoV-2 and humans: Implications for SARS-CoV-2 detection
    Li, Heng
    Hong, Xiaoping
    Ding, Liping
    Meng, Shuhui
    Liao, Rui
    Jiang, Zhenyou
    Liu, Dongzhou
    FRONTIERS IN GENETICS, 2022, 13
  • [26] Analysis of Spread Dynamics of Coronavirus SARS-CoV-2, SARS-CoV and MERS-CoV
    Liang K.-H.
    Zhang W.-F.
    Zhang X.-H.
    Wu Z.-K.
    Liu Q.
    Zhang C.-L.
    Li Z.-L.
    Dianzi Keji Daxue Xuebao/Journal of the University of Electronic Science and Technology of China, 2020, 49 (03): : 349 - 356
  • [27] Interactome of human and SARS-CoV-2 proteins to identify human hub proteins associated with comorbidities
    Ghosh, Nimisha
    Saha, Indrajit
    Sharma, Nikhil
    COMPUTERS IN BIOLOGY AND MEDICINE, 2021, 138
  • [28] Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics
    Gurwitz, David
    DRUG DEVELOPMENT RESEARCH, 2020, 81 (05) : 537 - 540
  • [29] SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review
    Carvalho Nascimento Junior, Jose Adao
    Santos, Anamaria Mendonca
    Quintans-Junior, Lucindo Jose
    Bandero Walker, Cristiani Isabel
    Borges, Lysandro Pinto
    Serafini, Mairim Russo
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2020, 30 (08) : 567 - 579
  • [30] Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing
    Krishnamoorthy, Pandikannan
    Raj, Athira S.
    Roy, Swagnik
    Kumar, Nachimuthu Senthil
    Kumar, Himanshu
    COMPUTERS IN BIOLOGY AND MEDICINE, 2021, 128